Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412047 · ClinicalTrials.gov registry record
Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 75
- Enrollment target
NCT01412047: Completed study, sponsored by Alexion Pharmaceuticals.
NCT01412047 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01412047 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
How does long term treatment with Soliris affect HAHA in PNH patients?
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-06-30 |
What the finished NCT01412047 record still lists
NCT01412047 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01412047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01412047 about?
NCT01412047 is a clinical study titled "Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study". How does long term treatment with Soliris affect HAHA in PNH patients?
What is the current status of trial NCT01412047?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2012-03. Estimated completion is 2013-06-30.
Who is sponsoring clinical trial NCT01412047?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia